Menu ×

HEALTHCARE & PHARMACEUTICAL

Voiding Cystourethrogram Market Segmentated By Product Type (Voiding Cystourethrogram (VCUG) and Fluoroscopic or Radionuclide Cystogram (RNC)); By Age (Adult Voiding Cystourethrogram and Pediatric Voiding Cystourethrogram); By End Use (Hospitals, Specialty Clinics and Radiology Centers)- Global Demand Analysis & Opportunity Outlook 2027

  • Text Size:

Introduction to Voiding Cystourethrogram

A Voiding Cystourethrogram is also known as Cystogram, is a radiological study to estimate the structure and functional attributes of urinary system. This process includes application of radiation and an X-ray machine to determine the functional behavior of the urinary system while the bladder is filled with liquid contrast materials. Cystourethrogram deals with the disorders related to bladder, urethra, uterus and kidney. There are two types of cystograms, VCUG and RNC. Both tests have similar preparation and process but uses different techniques to show the results.

Voiding cystourethrography (VCUG) is a procedure commonly performed by pediatric radiologists. This VCUG examination in conjunction with sonography is one part of the imaging workup of a febrile infant or child with a urinary tract infection (UTI). A radionuclide cystogram (RNC), is a diagnostic imaging exam that determines child’s vesicoureteral reflux, which occurs when urine flows from the bladder back up into the kidneys.

Market Size and Forecast

The global voiding cystourethrogram market is observing prominent growth on account of increasing healthcare concerns and awareness among people for check-ups. Advancement in healthcare industry in the past few years and growing research and development has encouraged disease detections easy and affordable which is projected to drive Voiding Cystourethrogram market along with growing population and rise in per capita income. The growth in healthcare department accompanied by insurance policies for refund in treatment is expected to propel the growth of the market during the forecast period. CLICK TO DOWNLOAD FREE SAMPLE

Voiding Cystourethrogram Market

According to American Urological Association, there are 150 million patients with UTIs occurring worldwide latest by Feb, 2019 and U.S is experiencing 1 million UTIs every year which is expected to project the growth of the voiding cystourethrogram in the market during the forecast period.

Growth Drivers

Growing Incidence of Urinary Tract Infections

Rising urinary diseases in urinary tract of children and adults are initiating the demand for Voiding Cystourethrogram market sturdily. The growing healthcare expenditure and rising disposable income of the people has encouraged regular clinical visits which helps in better detection of diseases at an early stage through the help of Voiding Cystourethrogram. Additionally, high prevalence of infection among children are probable to project the growth of the market at a high space during the forecast period. Growing population in developing countries coupled with increasing healthcare insurances have also triggered the demand for Voiding Cystourethrogram.

Rising Imaging Procedures

Latest technological advancements and investments in research and development by healthcare centers have influenced increasing the number of imaging centers in developed and developing countries across the globe. Additionally, the growing population and increasing urinary diseases are escalating the imaging procedures and thus impacting the market positively. Moreover, high consumer awareness for health and regular diagnosis has incorporated high investment by private associations to set up imaging centers in numerous countries round the world. Growing awareness in urban areas have also facilitated the growth in number of imaging centers and thus escalating the growth of Voiding Cystourethrogram market during the forecast period.

Restraints

High Cost

High cost for voiding cystourethrogram examination can obstruct the market growth during the forecast period. Additionally, the technology is out of affordability state of people in rural areas where prevalence of urinary diseases are high enough to diagnose.

Market Segmentation

Our-in depth analysis of the global Voiding Cystourethrogram market includes the following segments:

By Product Type           

  • Voiding Cystourethrogram (VCUG)
  • Fluoroscopic Or Radionuclide Cystogram (RNC)

By Age

  • Adult Voiding Cystourethrogram
  • Pediatric Voiding Cystourethrogram

By End Use

  • Hospitals
  • Specialty Clinics
  • Radiology Centers

By Region

On the basis of regional analysis, global Voiding Cystourethrogram market is segmented into five major regions including North America, Europe, Asia Pacific, Latin America and Middle East & Africa region.

Voiding Cystourethrogram market is expected to be dominated by North America on account of rising health expenditure and increasing diagnostic centers in this region. Additionally, the growing number of people for regular check-ups owing to awareness has increased number of imaging centers, thus expected to propel the growth of the market in the forecast period. The incidence of pediatric urology ailments, primarily urinary tract infections, is prevailing high which also contributes to the market growth of the voiding cystourethrogram market for this region.

Europe is expected to drive demand and positively impact Voiding Cystourethrogram market growth over the forecast period owing to improved healthcare infrastructure and growing facilities provided by government funding to the healthcare centers. Additionally, Asia Pacific is also expected to hold a prominent growth in this market on the back of increasing population and growing per capita income of the people in growing economies such as China and India. Moreover, the increasing urbanization and awareness among people for health expenditure in Asia Pacific region is expected to project high growth of the market during the forecast period.

Global Voiding Cystourethrogram market is further classified on the basis of region as follows:

  • North America (United States, Canada), Market size, Y-O-Y growth Market size, Y-O-Y growth & Opportunity Analysis, Future forecast & Opportunity Analysis
  • Latin America (Brazil, Mexico, Argentina, Rest of LATAM), Market size, Y-O-Y growth, Future forecast & Opportunity Analysis
  • Europe (U.K., Germany, France, Italy, Spain, Hungary, BENELUX (Belgium, Netherlands, Luxembourg), NORDIC (Norway, Denmark, Sweden, Finland), Poland, Russia, Rest of Europe), Market size, Y-O-Y growth, Future forecast & Opportunity Analysis
  • Asia-Pacific (China, India, Japan, South Korea, Malaysia, Indonesia, Taiwan, Hong Kong, Australia, New Zealand, Rest of Asia-Pacific), Market size, Y-O-Y growth, Future forecast & Opportunity Analysis
  • Middle East and Africa (Israel, GCC (Saudi Arabia, UAE, Bahrain, Kuwait, Qatar, Oman), North Africa, South Africa, Rest of Middle East and Africa), Market size, Y-O-Y growth, Future forecast & Opportunity Analysis

Top Companies Dominating the Market

  • Merck & Co., Inc.
    • Company Overview
    • Business Strategy
    • Key Product Offerings
    • Financial Performance
    • Key Performance Indicators
    • Risk Analysis
    • Recent Development
    • Regional Presence
    • SWOT Analysis
  • Koninklijke Philips N.V.
  • General Electric Company
  • Block Imaging International, Inc.
  • Carestream Health, Inc. 
  • Siemens AG
  • BMI Biomedical International s.r.l.
  • Hitachi Medical Systems
  • Medtronic
  • FUJIFILM Holdings Corporation

 

Factors Covered for Market Penetration
Factors to be Considered for maximum ROI
Connect with our Analyst

Related Reports


Disclaimer | Privacy Policy | Terms & Conditions

Copyright © 2019 Research Nester. All Rights Reserved

paypal visa americanexpress discover mastercard wire-transfer DMCA